XXVII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2022)
The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 29 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts around 1.000 participants both from industry and academia. The most recent EFMC-ISMC meeting took place in Slovenia (Ljubljana, 2018), while the edition initially planned for Basel, Switzerland in 2020 has been run as a Virtual Event in 2021.
The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer. EFMC-ISMC 2022 will also feature most recent advances in new technologies such as the exploitation of RNA as drug target, artificial intelligence in drug discovery, natural products-based drug discovery, DNA encoded libraries applications and the development of covalent drugs, PROTACs and molecular glues. Innovative approaches in medicinal chemistry will be included such as the development of immunomodulating compounds or the application of affinity selection – mass spectrometry for drug discovery. In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such as in vivo chemistry for target discovery and validation, molecular imaging, and photochemical approaches. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.
Deadlines
Calendar of Abstract Submissions
- Deadline for Oral Communication submission and free Poster submission: March 24, 20212, 24:00 CET
- Announcement of the accepted oral communications: mid May 2022
- After March 24 and until June 23, 2022, abstracts for Posters can still be submitted, but with a handling fee of 50,00€
Registration Fees
- Early-bird registration deadline: March 24, 2022
Payment of the Early-bird fee is required by April 8, 2022 in order to remain applicable. - Standard registration deadline: July 5, 2022
- Late registration deadline: September 4, 2022
- French Medicinal Chemistry Society (Société de Chimie Thérapeutique, SCT) (France)
- European Federation for Medicinal Chemistry and Chemical Biology (EFMC)
XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021)
The International Organising Committee has decided that the XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021) will be run as a fully Virtual Event, from August 29 to September 2, 2021. We are convinced that this is the right decision to allow many scientists to safely take part in this important scientific gathering.
Participants will be able to join the event via a digital platform, with content accessible during and after the symposium:
- Online Sessions – Live broadcast of the full scientific programme, with Q&A for interaction with the speakers.
- Replay – all sessions will be available on replay to all registered participants.
- Virtual Poster Hall – for all participants to present and discuss their latest scientific results.
- Virtual Exhibition – to give industry partners the opportunity to showcase products and novelties.
EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer. EFMC-ISMC 2021 will also feature most recent advances in new technologies such as, artificial intelligence in drug discovery and chemical synthesis, the role carbohydrates in disease pathology and carbohydratge-based drug discovery, the exploitation of RNA as drug target, small molecule-induced stem cell differentiation, or the impact of cryo-EM on drug discovery and design. In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such the use of chemical probes for target discovery, molecular imaging, and photochemical approaches. In response to frequent requests by attendees of previous conferences, two sessions will be dedicated to advances in synthetic methodology for drug discovery. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.
More information available on www.efmc-ismc.org.
- Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
- European Federation for Medicinal Chemistry and Chemical Biology (EFMC)
EFMC-ISMC Virtual Event 2020
First Time Disclosures & Late Breaking News
Due to the coronavirus pandemic, the XXVI EFMC International Symposium on Medicinal Chemistry in Basel has been postponed to August 29 - September 2, 2021.
A 2-days Virtual Event took place on September 7-8, 2020. Two online Sessions focused on First Time Disclosures & Late Breaking News.
Have a look at the Programme here!
XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018)
The XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018) was organised by the Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society, on behalf of the European Federation for Medicinal Chemistry (EFMC).
The 2018 edition covered drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology.
EFMC-ISMC 2018 presented the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some out-of-the-box areas of Medicinal Chemistry including carbohydrate-based vaccines and new chemical modalities, while Chemical Biology approaches to target identification will cover the interfaces between chemistry, biology and experimental medicine.
- Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society (Slovenia)
- European Federation for Medicinal Chemistry and Chemical Biology (EFMC)
XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016)
The XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) was organised by the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).
The 2016 edition continued the tradition of covering recent progress in drug research in major therapeutic areas, including the treatment of pain, CNS disorders, infections, cardiovascular diseases and cancer.
EFMC-ISMC 2016 will present the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. The impact of biomarkers and imaging at the interfaces between chemistry, biology and experimental medicine will be illustrated. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of novel organic synthesis in drug discovery.
- The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)
- European Federation for Medicinal Chemistry and Chemical Biology (EFMC)
XXIII EFMC International Symposium on Medicinal Chemistry
EFMC-ISMC 2014 in Lisbon, Portugal was organised by the Portuguese Chemical Society (SPQ). EFMC-ISMC 2014 continued the tradition of the ISMC Symposia to create an international platform where scientists from all over the world meet and exchange their view and ideas.
The scientific programme of EFMC-ISMC 2014 covered drug discovery advances in the major therapeutic areas, including neglected diseases, CNS disorders, inflammation, metabolic disorders, and oncology. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and organic synthesis which had a strong impact on medicinal chemistry.
- Division of Medicinal Chemistry of the Portuguese Chemical Society (Portugal)
XXII EFMC International Symposium on Medicinal Chemistry
EFMC-ISMC 2012 in Berlin, Germany was be jointly organised by the Division of Medicinal Chemistry of the German Chemical Society (GDCh) and the Section of Pharmaceutical/Medicinal Chemistry of the German Pharmaceutical Society (DPhG). EFMC-ISMC 2012 continued the tradition of the ISMC Symposia to create an international platform where scientists from all over the world meet and exchange their view and ideas.
The scientific programme of EFMC-ISMC 2012 covered drug discovery advances in all major therapeutic areas as well as the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. Particular emphasis was put on first time disclosures. EFMC-ISMC 2012 also illustrated the impact of the -omics and biomarker areas on the interfaces between chemistry, informatics, biology and experimental medicine.
- German Pharmaceutical Society, Section of Pharmaceutical/Medicinal Chemistry (Germany)
XXI EFMC International Symposium on Medicinal Chemistry
EFMC-ISMC 2010 was organised by the Medicinal Chemistry Divisions of the "Société Royale de Chimie (SRC)" and the "Koninklijke Vlaamse Chemische Vereniging (KVCV)", on behalf of the European Federation for Medicinal Chemistry.
EFMC-ISMC 2010 continued the tradition established by these biennial International Symposia and covered drug discovery advances in all major therapeutic areas, as well as the most recent advances in lead identification and optimization strategies, in drug design and development, and in prediction of activity as well as of adverse effects. An emphasis was on first time disclosures, emerging drugs and emerging technologies, including nanatechnologies and the chemical modulation of stem cells. ISMC 2010 also illustrated the impact of the omics and biomarker area on the interfaces between chemistry, informatics, biology and experimental medicine.
- Medicinal and Bioorganic Chemistry Division of Royal Flemish Chemical Society (KVCV) (Belgium)
- Medicinal Chemistry Division of the Société Royale de Chimie (SRC) (Belgium)
XX EFMC International Symposium on Medicinal Chemistry
The Symposium will focus on important new scientific and technological developments in the drug discovery process; particularly those relevant to medicinal chemistry. The meeting will create an environment for in-depth, informed discussions highlighting the importance of medicinal chemistry in the pharmaceutical industry, academia and drug research. It will also provide opportunities to re-emphasise the crucial position of medicinal chemistry in the drug discovery process and its pivotal role in linking and exploiting the associated biological sciences. Therefore, ISMC-2008 intends to create a forum for all scientists interested in medicinal chemistry and related fields.
- Austrian Chemical Society, Medicinal Chemistry Section (Austria)
XIX EFMC International Symposium on Medicinal Chemistry
The Symposium will focus on important new scientific and technological developments in the drug discovery process; particularly those relevant to medicinal chemistry. The meeting will create an environment for in-depth, informed discussions highlighting the importance of medicinal chemistry in the pharmaceutical industry, academia and drug research. It will also provide opportunities to re-emphasise the crucial position of medicinal chemistry in the drug discovery process and its pivotal role in linking and exploiting the associated biological sciences. Therefore, the ISMC-2006 intends to create a forum for all scientists interested in medicinal chemistry and related fields.
- Turkish Association of Medicinal and Pharmaceutical Chemistry (Turkey)
XVIII EFMC International Symposium on Medicinal Chemistry
The XVIIIth ISMC will reflect that medicinal chemistry is a scientific discipline undergoing rapid development. The molecular biological revolution, new drug design technologies and the progressing mapping of the human genome have created a new exciting working field for scientists in these research areas. These developments are continuously broadening the borderlands between chemistry, informatics and biology and provide new opportunities for drug design on a rational basis. The ISMC 2004 will illustrate the integration of the complementary industrial and academic drug design approaches.
- The Danish Society for Medicinal Chemistry and Chemical Biology (Denmark)
- Swedish Pharmaceutical Society (Sweden)
XVII EFMC International Symposium on Medicinal Chemistry
The Symposium focussed on the following topics:
- New methods and technologies in drug discovery
- Development of chemical libraries
- Early ADMET assessment
- Special topics in organic chemistry oriented to drug development
- Spanish Society of Medicinal Chemistry (Sociedad Española de Química Terapéutica) (Spain)
XVI EFMC International Symposium on Medicinal Chemistry
Main topics inlcuded:
- Antihypertensive Agents
- The Impact of Organic Chemistry on Drug Discovery
- Antiinfective Agents
- Hypolipidemics/Antiatherosclerotics
- Anticancer Agents
- Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI) (Italy)
XV EFMC International Symposium on Medicinal Chemistry
The following themes were included in the coverage:
- New Technologies for Drug Discovery
- Ion Channels
- Intracellular Signalling
- Glycine Antagonists
- Predicting DMPK
- Growth Factors
- Glycochemistry and Glycobiology
- 7TM Receptors
- Protease Inhibition
- The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)
XIV EFMC International Symposium on Medicinal Chemistry
Major topics:
- Methodology and Design in Medicinal Chemistry
- The Genome as Target for Drug Design
- Enzymes and Enzyme-inhibitors
- CNS agents
- Antibacterial and Antifungal Drug Discovery
- Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)
- Medicinal Chemistry Division of the Société Royale de Chimie (SRC) (Belgium)